Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity
JA Malik, G Kaur, JN Agrewala - International Journal of Biological …, 2023 - Elsevier
Toll-like receptors play a vital role in cell-mediated immunity, which is crucial for the immune
system's defense against pathogens and maintenance of homeostasis. The interaction …
system's defense against pathogens and maintenance of homeostasis. The interaction …
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
H Liang, M Cui, J Tu, X Chen - Frontiers in Cell and Developmental …, 2024 - frontiersin.org
Osteosarcoma, a malignant bone tumor predominantly affecting children and adolescents,
presents significant therapeutic challenges, particularly in metastatic or recurrent cases …
presents significant therapeutic challenges, particularly in metastatic or recurrent cases …
A TLR4 agonist induces osteosarcoma regression by inducing an antitumor immune response and reprogramming M2 macrophages to M1 macrophages
I Richert, P Berchard, L Abbes, A Novikov, K Chettab… - Cancers, 2023 - mdpi.com
Simple Summary Due to the lack of progress in OsA's treatment and survival, there is a need
to develop new therapeutic approaches for this tumor. OsA is a complex tumor for which the …
to develop new therapeutic approaches for this tumor. OsA is a complex tumor for which the …
DNA sensing of dendritic cells in cancer immunotherapy
W Qian, J Ye, S Xia - Frontiers in Molecular Biosciences, 2024 - frontiersin.org
Dendritic cells (DCs) are involved in the initiation and maintenance of immune responses
against malignant cells by recognizing conserved pathogen-associated molecular patterns …
against malignant cells by recognizing conserved pathogen-associated molecular patterns …
[HTML][HTML] Establishment of an immunogenic cell death-related model for prognostic prediction and identification of therapeutic targets in endometrial carcinoma
Z Liu, Y Huang, P Zhang, C Yang, Y Wang, Y Yu… - Aging (Albany …, 2024 - ncbi.nlm.nih.gov
Objective: Studies have firmly established the pivotal role of the immunogenic cell death
(ICD) in the development of tumors. This study seeks to develop a risk model related to ICD …
(ICD) in the development of tumors. This study seeks to develop a risk model related to ICD …
Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand
V Temchura, JT Wagner, D Damm - Pharmaceutics, 2023 - mdpi.com
Infectious diseases are a predominant problem in human health. While the incidence of
many pathogenic infections is controlled by vaccines, some pathogens still pose a …
many pathogenic infections is controlled by vaccines, some pathogens still pose a …
Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells
Understanding the intricacies of the metabolic phenotype in immune cells and its plasticity
within the tumor microenvironment is pivotal in understanding the pathology and prognosis …
within the tumor microenvironment is pivotal in understanding the pathology and prognosis …
[HTML][HTML] Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an …
Y Liu, T Corbascio, J Huang, J Engellau… - Journal of Functional …, 2024 - mdpi.com
Osteosarcoma treatment comprises pre-surgical chemotherapy followed by radical surgery
and further chemotherapy cycles, but the prognosis has been far from satisfactory. No new …
and further chemotherapy cycles, but the prognosis has been far from satisfactory. No new …
Targeted Biological and Cellular Immunotherapies for Osteosarcoma
GM Robbins - 2023 - search.proquest.com
Osteosarcoma (OSA) is the most common cancer of the bone and third most common cancer
diagnosed in children and adolescent. The five-year survival rate for OSA patients …
diagnosed in children and adolescent. The five-year survival rate for OSA patients …